Request Deal Involvement

Ally Bridge Group and Avidity Partners led a $101m Series B round in Endeavor BioMedicines.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Canale Communications

pr advisors

Canale Communications

or

Principals

ALLY BRIDGE GROUP

bidder

ALLY BRIDGE GROUP

OMEGA FUNDS

bidder

OMEGA FUNDS

TEKLA CAPITAL MANAGEMENT LLC

bidder

TEKLA CAPITAL MANAGEMENT LLC

T. ROWE PRICE GROUP INC

bidder

T. ROWE PRICE GROUP INC

LONGITUDE CAPITAL MANAGEMENT CO LLC

bidder

LONGITUDE CAPITAL MANAGEMENT CO LLC

ENDEAVOR BIOMEDICINES

target

ENDEAVOR BIOMEDICINES

AVIDITY PARTNERS

bidder

AVIDITY PARTNERS

PERCEPTIVE ADVISORS LLC

bidder

PERCEPTIVE ADVISORS LLC

PIPER HEARTLAND HEALTHCARE CAPITAL

bidder

PIPER HEARTLAND HEALTHCARE CAPITAL

REVELATION PARTNERS

bidder

REVELATION PARTNERS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite